日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Drug Prices, Rebates, and Health Plan Coverage Restrictions

药品价格、回扣和医疗保险计划承保范围限制

Beinfeld, Molly T; LaMountain, Fariel; Phillips, Glenn A; Hughes, Tom; Chambers, James D

Use of clinical outcome assessments in specialty drug coverage policies

在专科药物医保政策中使用临床结果评估

Rucker, Julia A; Poon, Jiat Ling; LaMountain, Fariel C A; Lin, Yichen; Klopchin, Megan N; Beinfeld, Molly T; Chambers, James D

What drug characteristics explain the wide range of manufacturer rebates?

哪些药物特性可以解释制造商折扣幅度如此之大的原因?

Beinfeld, Molly T; LaMountain, Fariel; Phillips, Glenn; Hughes, Tom; Neumann, Peter J; Chambers, James D

The unintended consequences of the inflation reduction act on biosimilar market incentives and Medicare savings

通胀抑制法案对生物类似药市场激励和医疗保险节省的意外后果

Beinfeld, Molly T; Ghule, Priyanka; LaMountain, Fariel; Wong, William; Ko, Stella; Chambers, James D

Biosimilar underutilization alone does not foretell a broken biologics market

生物类似药利用不足本身并不能预示着生物制剂市场将会崩溃。

LaMountain, Fariel; Beinfeld, Molly T; Wong, William; Kim, Eunice; Chambers, James D

Test implementation of a school-oriented drug prevention program "Study without Drugs": pre- and post-testing for effectiveness

学校禁毒项目“无毒学习”实施试验:前后测效果评估

Ishaak, Fariel; de Vries, Nanne Karel; van der Wolf, Kees

Oral probiotic control skin inflammation by acting on both effector and regulatory T cells

口服益生菌通过作用于效应T细胞和调节性T细胞来控制皮肤炎症。

Hacini-Rachinel, Feriel; Gheit, Hanane; Le Luduec, Jean-Benoit; Dif, Fariel; Nancey, Stéphane; Kaiserlian, Dominique